Related Experiment Video

Updated: Jun 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

[Insulin pump therapy in children and teenagers]

Carl Henrik Bergholtz1, Birthe Olsen, Jesper Johannesen

  • 1Glostrup Hospital, Børneafdelingen.

Ugeskrift for Laeger
|June 9, 2009
PubMed

Insights

Insulin pump use in Danish pediatric diabetes clinics surged 500% between 2002-2006. More robust, prospective trials are needed to confirm benefits of insulin pump therapy for children with diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology

Background:

  • Significant increase in insulin pump usage among Danish pediatric diabetes patients (approx. 500% from 2002-2006).
  • Existing evidence supporting insulin pump therapy primarily relies on retrospective studies.

Purpose of the Study:

  • To evaluate the benefits of insulin pump therapy in children and adolescents with diabetes.
  • To assess healthcare resource utilization associated with insulin pump therapy.

Main Methods:

  • Review of existing evidence on insulin pump therapy.
  • Call for well-organized, longer-term, prospective randomized controlled trials (RCTs).

Main Results:

  • Retrospective studies suggest potential benefits of insulin pump therapy.
  • Limited prospective data exists, particularly regarding healthcare professional resource use.

Conclusions:

  • Further high-quality prospective research, including RCTs, is essential.
  • Evidence is insufficient to definitively confirm improved outcomes or cost-effectiveness of insulin pump therapy in pediatric diabetes.
  • Future studies should focus on resource implications for healthcare professionals.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...